Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2020-21 | Page 124

### 29. Finance Cost

Amount in Taka

| Particulars | Note | July 2020- June 2021 | July 2019- June 2020 |
|---|---|---|---|
| Interest on Bank Borrowings | | 578,560,598 | 787,650,804 |
| Interest on Lease Liability | | 36,342,986 | 28,711,869 |
| Interest on Loan from PF, WPPF & Welfare Fund | | 190,970,118 | 166,837,043 |
| Other Bank Charges | | 52,811,444 | 30,604,369 |
| **Total** | | **858,685,146** | **1,013,804,085** |

### 30. Income Tax Expenses

This consists of as follows :

| Particulars | Note | July 2020- June 2021 | July 2019- June 2020 |
|---|---|---|---|
| (a) Current Tax | | 1,386,678,310 | 1,086,668,418 |
| (b) Deferred Tax Expense | | (174,879,849) | 22,288,436 |
| **Total** | | **1,211,798,461** | **1,108,956,854** |

### 31. Other Comprehensive Income/(Loss)

| Particulars | Note | July 2020- June 2021 | July 2019- June 2020 |
|---|---|---|---|
| Fair Value Gain/(Loss) on Investment in Listed Shares | | 12,840,831 | (1,577,828) |
| **Total** | | **12,840,831** | **(1,577,828)** |

### 32. Earnings Per Share (EPS)/ Restated EPS

| Particulars | Note | July 2020- June 2021 | July 2019- June 2020 |
|---|---|---|---|
| (a) Earnings attributable to the Owners of the Company | | 5,127,693,711 | 3,514,687,301 |
| (b) Weighted average number of Shares outstanding during the year | | 446,112,089 | 446,112,089 |
| **Earnings Per Share (EPS)/ Restated EPS** | | **11.49** | **7.88** |

### 33. Net Asset Value (NAV) Per Share

Amount in Taka

| Particulars | Note | June 30, 2021 | June 30, 2020 |
|---|---|---|---|
| Total Assets | | 52,246,084,026 | 50,118,741,940 |
| Less Total Liabilities | | (14,881,219,197) | (17,321,292,327) |
| Less Non-controlling Interest | | (334,306,627) | (302,329,006) |
| **Equity Attributable to the Owners of the Company** | | **37,030,558,202** | **32,495,120,607** |
| Number of Ordinary Shares | | 446,112,089 | 405,556,445 |
| **Net Asset Value (NAV) Per Share** | | **83.01** | **80.12** |

### 34. Net Operating Cash Flows Per Share (NOCFPS)

Amount in Taka

| Particulars | Note | July 2020- June 2021 | July 2019- June 2020 |
|---|---|---|---|
| Net Cash Generated from Operating Activities | | 6,023,263,955 | 5,542,487,221 |
| Number of Ordinary Shares | | 446,112,089 | 405,556,445 |
| **Net Operating Cash Flows Per Share (NOCFPS)** | | **13.50** | **13.67** |